NSERC Engage Research Grants Awarded to Study Antibodies & Vaccines
Biopharmaceutical specialists, Qu Biologics Inc., has been awarded Canadian government funding to study the unspecified lifecycle of administered antibodies. Over the next six months, the business will collaborate with the University of Ottawa’s Dr. Adam Shuhendler to carry out this research project. Qu Biologics Inc. will receive up to $25,000 in research grants through the…